This public event will be organised at the Lisbon School of Medicine, in person only.
In the first session Portuguese and Spanish researchers will present their recent findings and invite to discuss challenges in nuclear medicine.
In the second session PRISMAP news, results from the project and its user projects and needs of the User Forum will be in the focus.
|9.00||Welcome||Luís Costa (Hospital de Santa Maria; Faculdade de Medicina de Lisboa, Instituto de Medicina Molecular)|
|9.15||New approaches in cancer treatment: facts and expectations with medical radionuclides||Luis Costa|
|9.45||Delivering on the promise of theranostics - a pillar of progress in IPO Porto||Gonçalo Ferreira (IPO Porto)|
|10.25||ICNAS: 15 years of acceleration||Francisco Alves (ICNAS—Institute for Nuclear Sciences Applied to Health, University of Coimbra)|
|11.00||Phase 1 clinical trials with medical radionuclides||Bernard Doger (START Madrid- Jimenez Diaz Foundation University Hospital)|
|11.30||Round table discussion||Chairs: António Paulo, Luís Costa|
|14.00||PRISMAP – a short introduction||Thierry Stora (CERN)|
|14.15||Dedicated phantom measurements to develop and validate quantitative Ac-225-(micro)SPECT imaging||Michel Koole (KULeuven)|
|14.45||Development of a single-domain antibody for nuclear imaging and therapy of mesothelin expressing tumours||Alexis Broisat (INSERM)|
|15.15||Optimized cyclotron production of astatine: activity balance of At-211, At-210 and Po-210 after extraction chromatography||Matthijs Sevenois (VUB)|
|16.15||Optimization of the radiotheragnostic concept: Investigations of the next generation radionuclides||Cristina Müller (PSI)|
|16.45||News from PRISMAP||Thomas Elias Cocolios (KULeuven)|
|17.15||Conclusions||Charlotte Duchemin (CERN)|
|17.30||End of the meeting|